Speeda

Speeda

vaccine, rabies

Manufacturer:

Liaoning Chengda Biotechnology

Distributor:

Pharma-Surrey
Concise Prescribing Info
Contents
Lyophilized inactivated purified rabies vaccine prepared on Vero cells
Indications/Uses
Active immunization against rabies.
Dosage/Direction for Use
IM Preventive or pre-exposure vaccination Inj on days 0, 7, 28 w/ boosters during the 2nd & 6th yr of life. Post-exposure vaccination Adult & childn Inj on days 0, 3, 7, 14 & 28. Previously immunized subjects <5 yr 2 inj in days 0 & 3.
Contraindications
Hypersensitivity. Post-exposure therapy, pre-exposure prophylaxis.
Special Precautions
IV inj. Pregnancy & lactation.
Adverse Reactions
Pain, erythema, edema, pruritus, induration at inj site; moderate fever, shivering, faintness, asthenia, headache, dizzinesss, arthralgia, myalgia, GI disorders eg, nausea, abdominal pain; anaphylactiod reactions, urticaria, rash.
Drug Interactions
Corticosteroids, immunosuppressants.
ATC Classification
J07BG01 - rabies, inactivated, whole virus ; Belongs to the class of rabies viral vaccines.
Presentation/Packing
Form
Speeda vaccine (inj) 2.5 IU
Packing/Price
(vial + 0.5 mL diluent) 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in